Overview
Intranasal Dexmedetomidine Sedation for Pediatric CT Imaging
Status:
Unknown status
Unknown status
Trial end date:
2014-01-01
2014-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study has the objective to determine if intranasal dexmedetomidine, a sedative, is suitable for pediatric sedation in children undergoing tomographic scans.Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
University of Sao PauloCollaborators:
Boston Children's Hospital
Boston Children’s HospitalTreatments:
Dexmedetomidine
Criteria
Inclusion Criteria:- Children between 1 month to 15 years old undergoing CT scans in the pediatric
emergency department
Exclusion Criteria:
- Glasgow coma scale < 13
- Epistaxis or suspected base skull fracture
- Use of contrast or need for an IV line before sedation
- Uncontrolled gastroesophageal reflux or vomiting
- Current (or within past 3 months) history of apnea of prematurity requiring an apnea
monitor
- Acute, unstable respiratory disease
- Unstable cardiac status
- Craniofacial anomaly
- Medication use: digoxin
- Moya Moya Disease
- New onset stroke
- American Society of Anesthesiologists physical status ≥3